Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

Journal of Neurochemistry

Volumn 66, Issue 6, 1996, Pages 2429-2435

  Harr, Steven D ^a   Uint, Luciana ^a   Hollister, Richard ^a   Hyman, Bradley T ^a   Mendez, Armando J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Apolipoproteins; Senile plaques; Amyloid peptide

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN D; APOLIPOPROTEIN E; CLUSTERIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HOMOGENATE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; FRONTAL LOBE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHERITANCE; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0030001328     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66062429.x     Document Type: Article

References (44)

1. Bertrand P., Poirier J., Oda T., Finch C. E., and Pasinetti G. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol. Brain Res. 33, 174-178.
2. Boyles J. K., Notterpek L. M., and Anderson L. J. (1990) Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. J. Biol. Chem. 265, 17805-17815.
3. Corder E. H., Saunders A. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Rimmler J. B., Locke P. A., Conneally M., Schmader K. E., Small G. W., Roses A. D., Haines J. L., and Pericak-Vance M. A. (1994) Apolipoprotein E type 2 allele decreases the risk of late onset Alzheimer disease. Nature Genet. 7, 180-184.
4. Danik M., Chabot J.-G., Mercier C., Benabid A.-L., Chauvin C., Quirion R., and Suh M. (1991) Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death. Proc. Natl. Acad. Sci. USA 88, 8577-8581.
5. de Silva H. V., Harmony J. A. K., Stuart W. D., Gill C. M., and Robbins J. (1990) Apolipoprotein J: structure and tissue distribution. Biochemistry 29, 5380-5389.
6. Diedrich J. F., Minnigan H., Carp R. I., Whitaker J. N., Race R., Frey W. III, and Haase A. T. (1991) Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65, 4759-4768.
7. Garcia V., Fiol C., Hurtado I., Pinto X., and Argimon J. (1994) An enzyme-linked inununosorbent assay method to measure human apolipoprotein E levels using commercially available reagents: effect of apolipoprotein E polymorphism on serum apolipoprotein E concentration. Ann. Biochem. 223, 212-217.
8. Gearing M., Schneider J. A., Robbins R. S., Hollister R. D., Mori H., Games G., Hyman B. T., and Mirra S. S. (1995) Regional variation in the distribution of apolipoprotein E and Ab in Alzheimer's disease. J. Neuropathol Exp. Neurol. 54, 833-841.
9. Hixson J. E. and Vernier D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HAaI. J. Lipid Res. 31, 545-548.
10. Koudinov A., Matsubara E., Frangione B., and Ghiso J. (1994) The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem. Biophys. Res. Commun. 205, 1164-1167.
11. Kounnas M. Z., Loukinova E. B., Stefansson S., Harmony J. A. K., Brewer B. H., Strickland D. K., and Argraves W. S. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13070-13075.
12. LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23403-23406.
13. LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., and Falduto M. T. (1995) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9039-9042.
14. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
15. Li W. H., Tanimura M., Luo C. G., Datta S., and Chan L. (1988) The apolipoprotein multigene family: biosynthesis, structure, structure-function relationships, and evolution. J. Lipid Res. 29, 245-271.
16. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
17. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372, 92-94.
18. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
19. May P. C. and Finch C. E. (1992) Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci. 15, 391-396.
20. May P. C., Lampert-Etchells M., Johnson S. A., Poirier J., Masters J. N., and Finch C. E. (1990) Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat. Neuron 5, 831-839.
21. Mirra S. S., Heyman A., and McKeel D. (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
22. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541, 163-166.
23. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W., and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
24. Nitsch R. M., Rebeck G. W., Deng M., Richardson U. I., Tennis M., Schenk D. B., Vigo-Pelfrey C., Lieberburg I., Wurtman R. J., Hyman B. T., and Growdon J. H. (1995) Cerebrospinal fluid levels of amyloids-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apoE genotype. Ann. Neurol. 37, 512-518.
25. Pitas R. E., Boyles J. K., Lee S. H., Hui D., and Weisgraber K. H. (1987) Lipoproteins and their receptors in the central nervous system. J. Biol. Chem. 262, 14352-14360.
26. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
27. Poirier J., Hess M., May P. C., and Finch C. E. (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol. Brain Res. 11, 97-106.
28. Poirier J., Baccichet A., Dea D., and Gauthier S. (1993a) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55, 81-90.
29. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., and Gauthier S. (1993b) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342, 697-699.
30. Rebeck G. W., Reiter J. S., Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
31. Rebeck G., Chung H., Mendez A., Growdon J., and Hyman B. (1995) Form and function of apoE-containing lipoproteins in the CNS. Soc. Neurosci. Abstr. 21, 1008.
32. Roheim P. S., Carey M., Forte T., and Vega G. L. (1979) Apolipoproteins in human cerebrospinal fluid. Proc. Natl. Acad. Sci. USA 76, 4646-4649.
33. Rozovsky I., Morgan T. E., Willoughby D. A., Dugich-Djordjevich M. M., Pasinetti G. M., Johnson S. A., and Finch C. E. (1994) Selective expression of clusterin (SGP-2) and complement ClqB and C4 during responses to neurotoxins in vivo and in vitro. Neuroscience 62, 741-758.
34. Sanan D. A., Weisgraber K. H., Russell S. J., Mahley R. W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A., and Strittmatter W. J. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J. Clin. Invest. 94, 860-869.
35. Segrest J. P., Jones M. K., De Loof H., Brouillette C. G., Venkatachalapathi Y. V., and Anantharamaiah G. M. (1992) The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J. Lipid Res. 33, 141-166.
36. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., and Roses A. D. (1993a) Apolipoprotein E: high-avidity binding to β-amyloid and increased frequence of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
37. Strittmatter W. J., Weisgraber K. H., Huang D. Y., Dong L. M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
38. Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L.-M., Jakes R., Alberts M. J., Gilbert J. R., Han S.-H., Hulette C., Einstein G., Schmechel D. E., Pericak-Vance M. A., and Roses A. D. (1994) Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125, 163-171.
39. Tsai M.-S., Tangalos E. G., Petersen R. C., Smith G. E., Schaid D. J., Kokmen E., Ivnek R. J., and Thibodeau N. (1994) Apolipoprotein E: risk factor for Alzheimer's disease. Am. J. Hum. Genet. 54, 643-649.
40. West H. L., Rebeck G. W., and Hyman B. T. (1994) Frequency of the apolipoprotein E ε2 allele is diminished in sporadic Alzheimer disease. Neurosci. Lett. 175, 46-48.
41. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
42. Wisniewski T., Golabek A., Matsubara E., Ghiso J., and Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem. Biophys. Res. Commun. 192, 359-365.
43. Wisniewski T., Castano E. M., Golabek A., Vogel T., and Frangione B. (1994) Acceleration of Alzheimer's disease fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035.
44. Wisniewski T., Golabek A. A., Kida E., Wisniewski K. E., and Frangione B. (1995) Conformational mimicry in Alzheimer's disease. Am. J. Pathol. 147, 238-244.